急性脑梗死发作期间组织因子动态变化及药物干预性观察
被引量:1
摘要
斑块破裂伴随血栓形成是急性脑梗死的主要原因。组织因子作为外源性凝血因子途径的启动子.起着触发凝血链锁反应的重要作用。最近发现血栓形成时。组织因子(TF)途径发生了重要变化。TF是凝血过程的始动因子,凝血过程参与了血栓形成的机制。为此,我们选择了发病6~24h(超过溶栓时间窗)的急性脑梗死患者,研究TF及其相关因子在急性脑梗死发作期间的动态变化,TF与脑梗死患者预后状况及低分子肝素的作用。
出处
《中国药物与临床》
CAS
2008年第1期73-75,共3页
Chinese Remedies & Clinics
参考文献11
-
1吴丽娥 刘鸣 张月辉.缺血性脑卒中TOAST病因分型和预后[J].Arch surg,2005,140(12):1210-1217.
-
2脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15737
-
3Ghrib F,Brisset AC,Dupouy D,et al.The expression of tissue factor and tissue factor pathway inhibitor in aortic smooth muscle cells is up regulated in synthetic compared to-contractile phenotype.Thtomb Haemost,2002,87(6):1051-1054.
-
4Hatakeyama K,Asada Y,Marutsuk K,et al.Expression of tissue factor in the rabbit aorta after balloon injury.Atheroselerosis,1998,139(2):265-271.
-
5路亚枫,秦明照,翟艳苓,胡大一.冠心病患者血浆TF、TFPI水平的变化及其临床意义[J].中华急诊医学杂志,2004,13(3):191-193. 被引量:4
-
6Sardo MA,castaldo M,Bonaiuto A,et al.Tissue factor expression and activity were not increased in peripheral monocyles isolated from uncomplicated hypertensive patients.J Hypertens,2006,24(4):731-736.
-
7Migdalski A,Kotschy M,Jawien A..Tissue factor pathway and vascular endothelial growth factor-A in carotid atherosclerotic plagues.Eur J Vasc Endovasc Surg,2005,30:91.
-
8Barua RS,Ambrose TA,Saba DC,et al.Smoking is associated with endothelial-derived fibrinolytic and antithrombotic factors;an in vitro demonstration.Circulation,2002,106(8):905-908.
-
9Chi L,Gibson G,Peny YW,et al.Characterization of a tissue factor-factor-Ⅶ a-dependent model of thrombosis in hypercholesterolemic rabbits.J Thromb Haemost,2004,2:85-92.
-
10Steppich B,Mattisek C,Sobczyk D,et al.Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.Thromb Haemost,2005,93(1):35-39.
共引文献15739
-
1曹芳芳.通脑复原汤辅治脑梗死气虚血瘀证临床观察[J].实用中医药杂志,2020,0(2):208-209. 被引量:2
-
2凡蕾,吴佳欣,李俊锋,王鑫,刘荣.针刺对脑梗死后炎症因子表达和神经功能影响的Meta分析[J].中国老年学杂志,2024,44(9):2061-2066.
-
3黄金华,胡灵芝.丁苯酞联合双抗血小板对进展性脑梗死的宏观疗效和微观影响[J].浙江实用医学,2021,26(1):10-13.
-
4王自有.个性化康复训练联合人解语丹对中风失语早期功能康复效果的影响分析[J].智慧健康,2020(34):67-68.
-
5杨敏京,金昊.社区综合康复模式对卒中患者康复效果及心理状况的影响[J].慢性病学杂志,2021(1):76-78. 被引量:2
-
6时开英.神经节苷脂钠在急性脑梗死治疗中的应用效果及安全性分析[J].慢性病学杂志,2020(7):1027-1028.
-
7葛玉霞,于磊,侯丽芳.注射用丹参多酚酸治疗急性脑梗死的疗效观察[J].药物评价研究,2020,0(3):509-511. 被引量:7
-
8任会菊,乔洪潮,郑东焕,高园园,王常有,黄利红.注射用丹参多酚酸治疗急性脑梗死的疗效观察[J].药物评价研究,2020,0(3):502-505. 被引量:5
-
9冯涛.注射用丹参多酚酸对急性脑梗死患者NIHSS评分、ADL评分和血清NSE、GST的影响[J].药物评价研究,2020,0(3):498-501. 被引量:9
-
10董同忠,李玉岭,郭学义,王燕,路莎.注射用丹参多酚酸联合依达拉奉治疗急性脑梗死疗效分析及对血液流变学的影响[J].药物评价研究,2020,0(3):494-497. 被引量:23
同被引文献12
-
1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33008
-
2Zhang B,Ye S,Herrmann SM.et al.Functional polymorphism in the regulatory region of gnlatinese B gene in relation to severity of coronary atherosclerusis.Circutatlon,1999,99:1788-1794.
-
3Laftus IM,Naylor AR,Goodall S,et al.Increased matrix metalloproteinese-9 activity in unstable "carotid plaques:a potential role in acute plaque disruption.Stroke,2000,31 (1):40-47.
-
4Rosell A,Ortega-Aznar A,Alvarez-Sabin J,et al.Increased brain expression of matrix metalloproteinese-9 after ischemic and hemorrhagic human stroke.Stroke,2006,37(6):1399-1406.
-
5Planes AM,Sole S,Justicia C,et al.Estimation of gelatinese content in rat brain:effect of focal ischemia.Biocbem Biophy Res Commun,2000,278:803-807.
-
6Romanic AM,White RE,Arleth AJ,et al.Matrix metallopruteinese expression increases after cerebral focal ischemia in rats:inhibition of Matrix metalloproteinese-9 reduces infarct size.Stroke,1998,29:1020-1030.
-
7Cestellanos M,Leira R,Serena J,et al.Plasma metalloproteinaze-9 content ration predicts hemorrhagic transformation in acute ischemic stroke.Stroke,2003,34(1):40-46.
-
8Gu Z,Cui J,Brown S,et al.A highly specific inhibitor of matrix metalloproteinese-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.J Neurosci,2005,25(27):6401-6408.
-
9Galls ZS,Sukhova GK,Lark MW,et al.Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.J Clin Invest,1994,94:2493.
-
10Blankenberg S,Rupprecht HJ,Poirier O,et al.Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.Circulation,2003,107(12):1579-1585.
二级引证文献5
-
1刘丹,孙洪英,杨英,张广炜,杨静,贾培飞,吴丽娥,张伟,杨玉蓉,杨国安.MMP-2 C735T、MMP-9 C1562T基因多态性与缺血性卒中患者的卒中及其亚型大动脉粥样硬化性卒中有关,但与转归无关[J].国际脑血管病杂志,2011,19(7):503-509. 被引量:3
-
2刘丹,杨静,张广炜,吴丽娥,贾培飞,王亚春,张伟,杨国安.脑卒中患者基质金属蛋白酶基因多态性研究[J].中华老年心脑血管病杂志,2011,13(10):901-904. 被引量:4
-
3张明杰,李敬诚,刘赟,尹延伟,张莉莉.基质金属蛋白酶9基因-1562C/T多态性与缺血性卒中风险:汇总分析[J].国际脑血管病杂志,2013,21(7):522-526. 被引量:1
-
4刘旭,朱瑞霞,张健,李瞿,何志义.基质金属蛋白酶-9基因多态性与脑梗死相关性的Meta分析[J].解剖学研究,2016,38(3):182-186. 被引量:1
-
5刘旭,李瞿,张健,朱瑞霞,何志义.中国人MMP-9基因多态性与缺血性脑卒中关系的Meta分析[J].热带医学杂志,2016,16(6):752-755. 被引量:6
-
1刘清文,应惠蓓.150例脑梗死患者的颈动脉彩超检查的临床分析[J].中国医药指南,2013,11(6):523-524. 被引量:1
-
2张玉爱.脑卒中患者康复过程中发生并发症的危险因素与护理[J].齐鲁护理杂志,2002,8(12):929-930.
-
3班瑞益.难治性癫痫心理问题的干预性研究现状[J].右江医学,2012,40(5):728-730. 被引量:1
-
4李燕,李新玲,董政协,李嘉.缺血性卒中早发神经功能恶化的临床及影像学特征[J].齐齐哈尔医学院学报,2010,31(22):3573-3574.
-
5李娟,步国敏,章桂飞,陈先震.脑卒中患者吞咽障碍的康复护理[J].河北医学,2012,18(6):847-848. 被引量:5
-
6林显仙,王艳娜.急性脑血管意外并发症的危险因素分析及对策[J].护理实践与研究,2009,6(14):47-48. 被引量:5
-
7曾淑芝.颅脑损伤所致精神症状的预见性护理[J].中国民康医学,2006,18(22):877-877. 被引量:1
-
8朱以诚,崔丽英,华宝来,潘家绮.血浆纤维蛋白原水平与心脑血管疾病的相关性[J].中国医学科学院学报,2005,27(1). 被引量:3
-
9苏琳.干预性护理预防老年高血压脑卒中102例效果观察[J].齐鲁护理杂志,2006,12(07A):1243-1244. 被引量:1
-
10何群.构音障碍-手笨拙综合征1例干预性康复护理[J].齐鲁护理杂志(上旬刊),2011,17(4):103-103.